Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cancer cell membrane potential is an electrical property defined by the difference in electric potential across the plasma membrane in cancer cells, primarily governed by ion channels and transporters. Cancer cells display a depolarized resting membrane potential compared to normal cells, which is associated with increased proliferation, altered cell cycle progression, metastasis, and resistance to apoptosis. Vm fluctuations are not static but dynamically regulate several key cancer phenotypes, including migration, stemness, and cell division. Modulating the membrane potential, particularly through targeted ion channel inhibition or activation, is an emerging therapeutic strategy, though it presents substantial challenges due to the non-specific nature of the underlying mechanisms and potential for systemic side effects.
Ion channel blockade (e.g., sodium, potassium, calcium channels—alter Vm to arrest proliferation/migration). Modulation of ion channel expression/activity to induce hyperpolarization or depolarization, influencing cell cycle or apoptosis. Pulsed electric fields to manipulate Vm.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Membrane potential of cancer cell (Vm (when context specifies cancer cell)).